Avac Event

PrEP Trends & the Redesigned PrEPWatch

PrEPWatch is a one-stop online clearinghouse for resources and information to help the global community effectively deliver every proven method of PrEP to everyone who needs it. This webinar explored the newly relaunched site and walked through some of the latest features including better-than-ever curation, navigation, and search. We heard from leading advocates on what’s in the pipeline for prevention products and trends happening in PrEP uptake and delivery.

Recording / Slides / Resources

Avac Event

A Conversation with The London Patient: The second known person cured of HIV

Join us for a conversation with The London Patient, Adam Castillejo — only the second person cured of HIV. He will share his experience with the procedure that ultimately eradicated HIV from his body, why people should be hopeful about the state of the research, and what his life is like after HIV. Attendees will be able to ask questions and take photos with Adam after the event.

Learn more and register here.

Avac Event

Africa Health R&D Week

Africa Health R&D Week 2022 is designed to recognize achievements and step up advocacy for sustainable financing of health R&D through domestic resource mobilization (DRM) in Africa. The week contains a series of informative, networking, and motivational events for advocates, media, policymakers, program implementors, researchers, and funders to bring clarity to key issues and trends of DRM for health R&D on the continent. The content and programming of Africa Health R&D Week is informed by the various coalitions advocating for DRM for health.

Speakers:

  • Ogwell Ouma, Acting Director of Africa CDC
  • Parfait Uwaliraye, Ministry of Health, Rwanda
  • Jason Braganza, AFRODAD
  • Frances Illka, Palladium
  • Agnes Binagwaho, University of Global Health Equity
  • Vuyiseka Dubula, Stellenbosch University

Agenda / Concept Note / Flyers

Register here.

Avac Event

Much Accomplished, Much to Do: A Conversation Looking Back & Looking Ahead with Tony Fauci

AVAC Executive Director Mitchell Warren spoke with NIAID Director, Anthony Fauci to discuss all that’s been accomplished in the HIV and COVID-19 responses over the years, what’s ahead, and what the future looks like for NIAID, for Dr. Fauci and for pandemic preparedness.

Recording / Transcript

Avac Event

HIV, COVID-19, and Gender Inequality: A Call to Action

Many of the drivers of gender inequality in the HIV epidemic are the same as those driving inequality in the COVID-19 pandemic. During the COVID-19 pandemic, women and girls are at heightened risk of domestic violence and inadequate access of essential health care including HIV prevention and sexual and reproductive health services. To better prepare for the future, during this conversation we will discuss the imperative to address the underlying social factors like gender inequality that exacerbate these pandemics.

Register here.

Avac Event

Domestic Resource Mobilization Learning Collaborative

Thursday, December 8 at 15:00 PM EAT / 14:00 PM SAST/ 13:00 PM WAT / 8:00 AM EDT marks the launch of the inaugural Domestic Resource Mobilization (DRM) Learning Collaborative. The collaborative will be a facilitated virtual space that brings together global health advocates, civil society organizations and other key stakeholders from Africa to engage in peer-to-peer learning and collaboration. Topics will include local investments in health including HIV, pandemic preparedness, research and development (R&D), and use the time to explore opportunities and challenges, and frame what questions must be answered to develop a unifying advocacy agenda.

Register here.

Avac Event

2022 Global Health Landscape Symposium

The 2022 Global Health Landscape Symposium (GHLS2022) convened from December 7-8 asking the question “How do we meet this moment?” three years after an ongoing pandemic and three years since the Global Health Community last met in person. The agenda, videos and a partner toolkit are available here.

Avac Event

CROI 2023

The annual Conference on Retroviruses and Opportunistic Infections (CROI) took place from February 19 through February 22 in Seattle, Washington. This was the first in-person CROI since 2019, but also included the virtual component honed during COVID, with 3,000+ individuals registered to participate in-person and 500+ online.

Below are highlights from the conference:

Follow Along

Conference coverage was available via aidsmap, AVAC on Twitter at @hivpxresearch and the conference hashtag #CROI2023. Conference press conferences are posted here.

Preview CROI

The Choice Agenda hosted the webinar, Ready, Set, CROI 2023: Prepare for the 30th Year of CROI on February 13. Researchers previewed the program, veteran CROI advocates offered tips for navigating the conference, and researcher, Victoria Walker-Sperling broke down key features for lay audiences on understanding scientific presentations. Watch the full recording here.

Margarita Breakfast Club

AVAC, the CROI Community Liaison Subcommittees, European AIDS Treatment Group, and other partners hosted virtual Margarita Breakfast Clubs (MBCs) open to all.

advert for the margarita breakfast club

Monday, February 20
Arrested Development: Discontinuation of the MOSAICO Trial, its Legacy and Expectations for HIV Vaccine Research
Recording / Slides / Summary

Tuesday, February 21
Moving Forward: Upcoming Strategies on STI Prevention
Recording / Slides / Summary

Wednesday, February 22
The Data Gap: Filling in the Missing Perspectives on Women and Children in HIV Research
Recording / Resources / Summary

CROI Round-up

Read our round-up here and subscribe to our Advocates’ Network email list for more like this.

Avac Event

Where Are We Now and What’s Next?: Mosaico Study Update

A Phase 3 study of an investigational HIV vaccine regimen has been discontinued following a planned, interim review by the study’s independent Data and Safety Monitoring Board. The investigational vaccine was generally safe and well tolerated; however, it was not effective at preventing the acquisition of HIV-1.

The results of the uniquely designed and implemented Mosaico study underscore the challenges that have faced the global scientific community in the 40-year search for an HIV vaccine, and may provide important data in the ongoing fight against HIV. Join the HIV Vaccine Trials Network and AVAC and key voices from the study including study investigators and community representatives in this important webinar as we will discuss the outcome of the Mosaico study, and discuss what these results mean and next steps.

View the recording here.

title card with presentation info

Avac Event

Been There, Did That – Research Reflections from CROI 2023

Thursday, March 23 at 10:00–11:30am ET

Speakers will include community leaders and researchers reflecting on the most interesting, consequential science presented at CROI 2023.

Co-moderated by Devan Nambiar, Gay Men’s Sexual Health Alliance and CROI 2023 Community Educator Scholar

Featured researcher:
Dr. Monica Gandhi, UCSF

Featured community speakers:
CROI 2023 Community Educator Scholars

Register here.

This webinar is a part of The Choice Agenda.